ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.

March 1, 2002

Rall Says NTP to Put 50-75 Chemicals On Long Term Tests

January 19, 1979

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

An Impromptu Group Proposes Standards For Publication Of Genomics Research

October 1, 2010

Trials Approved by NCI CTEP For The Month of February

February 24, 2012